Catalyst Wire Dossier Catalyst Wire Dossier

BI 201335 NA soft gelatin capsules

BI 201335 · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 201335 NA soft gelatin capsules, covering 2015-07-31 to 2015-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Trial of 2 Dose Strengths of BI 201335 NA Soft Gelatine Capsules [Phase 1]

See pricing